PLoS Negl Trop Dis 15(9): e0009596. September 20, 2021 Authors: Reza A. Niles, Charles R. Thickstun, Horace Cox, Daniel Dilliott, Clara R. Burgert-Brucker, Emma
International Health, Volume 13, Issue Supplement_1, January 2021, Pages S55–S59 Published December 22, 2020 Authors: Alison Krentel, Margaret Gyapong, Deborah A McFarland, Olumide Ogundahunsi,
PLoS Negl Trop Dis 14(10): e0008565. Published October 8, 2020. Authors: Yao Sodahlon, David A. Ross, Carol McPhillips-Tangum , Joni Lawrence, Rachel Taylor, Deborah
This research article focuses on the results of four rounds of mass drug administration (MDA) for cross-border districts of Côte d’Ivoire where lymphatic filariasis
In order to confirm that transmission recrudescence or importation does not occur for lymphatic filariasis (LF) after mass drug administration (MDA), the WHO recommends
This research article examines the Ov16 (onchocerciasis) and Wb123 (lymphatic filariasis) seroprevalence in the Bakoye and Falémé foci in Mali after 24 – 25
Parasites Vectors 13, 258 (2020). Published May 15, 2020. Authors: Jérémy T Campillo, Cédric B Chesnais, Sébastien D Pion, Jacques Gardon, Joseph Kamgno, Michel
This editorial from Darin S. Evans raises important questions regarding the decision to stop mass drug administration (MDA) for countries with onchocerciasis as they
This research paper focuses on the first stop-Mass Drug Administration (MDA) decision for onchocerciasis in Nigeria. These findings can be modeled by other African
This research paper details the coordinated stop of MDA, decided by Sudan and Ethiopia, due to satisfying the World Health Organization’s criteria for interruption
Article on the importance of cross-border issues in onchocerciasis elimination programmes. Bush, Sodahlon, Downs and Mackenzie, International Health, Volume 10, Issue suppl_1, 1 March 2018,
Article on the use of alternative (or complementary) treatment strategies (ATSs) to accelerate the elimination of onchocerciasis. Boussinesq et al., International Health, Volume 10,
Article on eliminating onchocercias as a public health problem in Uganda. Katabarwa et al, International Health, Volume 10, Issue suppl_1, 1 March 2018, Pages
A review summarizing the progress made in identifying diagnostics that meet the specialized requirements needed to verify onchocerciasis elimination, as well as a discussion
Article on the acquisition of quality-assured (QA) data that ultimately define the absence of infection or transmission of onchocerciasis in previously endemic areas in Africa. International
This publication reviews the history of the efforts to control onchocerciasis in Yemen and the current status of the disease, and identifies the essential
